Literature DB >> 8114194

Intimal hyperplasia producing thrombus organization in an experimental venous thrombosis model.

B Sigel1, V Swami, A Can, R E Parsons, R M Golub, R Kolecki, H Kitamura.   

Abstract

PURPOSE: A venous thrombosis animal model demonstrated similarities between intimal hyperplasia and thrombus organization. This has prompted the evaluation of a hypothesis that intimal hyperplasia may be the mechanism for thrombus organization in veins with normal pressure.
METHODS: Thrombi were produced in surgically exposed jugular veins of anesthetized, 18 to 20 kg pigs. Thrombosis was induced by a combination of devascularization, electric injury produced by a low amperage, direct current, and permanent partial ligation (50% diameter reduction). Vein segments were harvested at 0, 1, 2, 7, 14, and 60 days and histologically examined for fibrin, red blood cells, platelets, smooth muscle cells, endothelial cells, elastic fibers, and collagen deposits.
RESULTS: Forty vein segments in 20 pigs were evaluated. Luminal thrombi with thickened walls developed in all specimens. All luminal thrombi demonstrated partial spontaneous thrombolysis over the period of observation. Intimal thickening consisting primarily of smooth muscle cells by day 2 was apparent and progressed until about 2 weeks, when collagen deposits became prominent within the neointima. The neointima frequently comprised half the cross-sectional area of the veins. Endothelial cells were present in the intima as single cells or as lining for clefts formed within the thickened intima.
CONCLUSIONS: Smooth muscle cell proliferation with collagen deposition characteristic of intimal hyperplasia seemed to be the mechanism of thrombus organization in the experimental thrombosis model used in this study in which extensive stimulation was used to produce thrombosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8114194     DOI: 10.1016/s0741-5214(94)70110-5

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  4 in total

1.  Early natural history of neotissue formation in tissue-engineered vascular grafts in a murine model.

Authors:  James W Reinhardt; Juan de Dios Ruiz Rosado; Jenny C Barker; Yong-Ung Lee; Cameron A Best; Tai Yi; Qiang Zeng; Santiago Partida-Sanchez; Toshiharu Shinoka; Christopher K Breuer
Journal:  Regen Med       Date:  2019-06-10       Impact factor: 3.806

2.  Cilostazol as a noninferiority pharmacologic option to paclitaxel in early intimal hyperplasia inhibition after venous balloon angioplasty in a rabbit model: a preliminary study.

Authors:  Rodrigo Lozano-Corona; Hugo Laparra-Escareno; Javier E Anaya-Ayala; Alejandro Zentella-Dehesa; Jesus J Baquera-Heredia; Ruben Argüero-Sánchez; Carlos A Hinojosa
Journal:  JVS Vasc Sci       Date:  2020-10-22

3.  Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus.

Authors:  Ellen G Driever; Fien A von Meijenfeldt; Jelle Adelmeijer; Robbert J de Haas; Marius C van den Heuvel; Chandrasekaran Nagasami; John W Weisel; Constantino Fondevila; Robert J Porte; Anabel Blasi; Nigel Heaton; Stephen Gregory; Pauline Kane; William Bernal; Yoh Zen; Ton Lisman
Journal:  Hepatology       Date:  2021-12-05       Impact factor: 17.298

Review 4.  The Effects of Pro-Inflammatory and Anti-Inflammatory Agents for the Suppression of Intimal Hyperplasia: An Evidence-Based Review.

Authors:  Rohaina Che Man; Nadiah Sulaiman; Mohamad Fikeri Ishak; Ruszymah Bt Hj Idrus; Mohd Ramzisham Abdul Rahman; Muhammad Dain Yazid
Journal:  Int J Environ Res Public Health       Date:  2020-10-26       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.